Does EVOLOCUMAB Cause Sinus disorder? 363 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 363 reports of Sinus disorder have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
363
Reports of Sinus disorder with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
1
Deaths
13
Hospitalizations
How Dangerous Is Sinus disorder From EVOLOCUMAB?
Of the 363 reports, 1 (0.3%) resulted in death, 13 (3.6%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Sinus disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 363 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Sinus disorder?
ADALIMUMAB (955)
ETANERCEPT (801)
DUPILUMAB (684)
LENALIDOMIDE (550)
TOFACITINIB (535)
PREDNISONE (519)
ALBUTEROL (491)
TREPROSTINIL (429)
HUMAN IMMUNOGLOBULIN G (398)
SECUKINUMAB (385)
Which EVOLOCUMAB Alternatives Have Lower Sinus disorder Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE